1. Home
  2. DTIL vs ZTR Comparison

DTIL vs ZTR Comparison

Compare DTIL & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

N/A

Current Price

$7.35

Market Cap

362.6M

Sector

Health Care

ML Signal

N/A

Logo Virtus Total Return Fund Inc.

ZTR

Virtus Total Return Fund Inc.

N/A

Current Price

$6.24

Market Cap

325.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
DTIL
ZTR
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
362.6M
325.0M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
DTIL
ZTR
Price
$7.35
$6.24
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $29.40
N/A
AVG Volume (30 Days)
★ 402.8K
89.8K
Earning Date
11-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,070,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.53
$5.92
52 Week High
$11.29
$7.11

Technical Indicators

Market Signals
Indicator
DTIL
ZTR
Relative Strength Index (RSI) 48.99 36.35
Support Level $6.12 $5.92
Resistance Level $7.80 $6.86
Average True Range (ATR) 0.93 0.10
MACD -0.22 -0.05
Stochastic Oscillator 17.63 4.90

Price Performance

Historical Comparison
DTIL
ZTR

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

About ZTR Virtus Total Return Fund Inc.

Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.

Share on Social Networks: